Dimensionality of parkinsonian signs in aging and Alzheimer's disease

Bennett, DA, KM Shannon, LA Beckett and RS Wilson

J. Gerontol. Ser. A-Biol. Sci. Med. Sci.. 1999. 54(4):M191-M196.

Background. Parkinsonian signs are commonly found on the neurologic examination of older persons and are associated with morbidity and mortality. The extent to which parkinsonian signs in aging and Alzheimer's disease cluster in groups typical of Parkinson's disease has not been investigated previously. Methods. The motor portion of the Unified Parkinson's Disease Rating Scale (UPDRS), or a version with minor modifications, was administered to more than 2,800 persons in three cohorts: (a) 637 older persons with a wide range of neurologic conditions participating in the Chicago Health and Aging Project, a study of common health problems of a random sample of older persons from a geographically defined biracial community population; (b) 638 relatively healthy and highly educated older persons from 25 Catholic religious communities participating in the Religious Orders Study, a longitudinal clinical-pathologic study of aging; and (c) 1,546 older persons undergoing evaluation for possible dementia at the Push Alzheimer's Disease Center, an urban, tertiary care center that evaluates persons for possible dementia. Separate factor analyses were performed on each data set. Additional analyses examined the factor structure in subsets by gender and race, Results. A similar grouping of items emerged in each cohort and did not differ substantially by gender or race. The factors corresponded closely with the traditional grouping of parkinsonian signs into bradykinesia, gait disturbance, rigidity, and tremor. Conclusions. The grouping of parkinsonian si,ans is consistent in diverse samples of older persons and does not vary substantially across gender or race. The results provide an empirical basis for summarizing the principal motoric manifestations of parkinsonism.

Keywords: amyloid; aging; dementia; cortex; histochemistry; plaques; tangles, Alzheimers-disease Cerad; Apolipoprotein-e; Memory Impairment; Transgenic Mice; Pathological-changes; Senile Plaques; Neurofibrillary Tangles; Nondemented Subjects; Parkinsons- Disease; Precursor Protein, Prose Recall; Intelligence; Performance; Community; Adults; age, Nursing-home Admission; Older Adults; Functional Status; Risk- Factors; Myocardial-infarction; Depressive Symptoms; Physical- Disability; Disablement Process; Elderly Persons; Multiple Roles, Extrapyramidal Signs; Rating-scale; Interrater Reliability; Individuals; Prevalence; Predictors; Mortality; Criteria; Dementia; Cohort



Close Window

UC Davis Health System is pleased to provide this information for general reference purposes only. It should not be considered as a substitute for professional medical advice. You are urged to consult with your health care provider for diagnosis of and treatment for any health-related condition. The information provided herein may not and should not be used for diagnosis and treatment.

Reproduction of material on this web site is hereby granted solely for personal use. No other use of this material is authorized without prior written approval of UC Regents.